Table 3.
Variables | Coefficients | 95% CI | SE | p-value |
---|---|---|---|---|
Total n | 0.004 | −0.003; 0.012 | 0.004 | 0.253 |
Vitiligo n | 0.003 | −0.009; 0.016 | 0.006 | 0.612 |
Controls n | 0.015 | −0.001; 0.031 | 0.008 | 0.059 |
Vitiligo-Male | 0.009 | −0.015; 0.034 | 0.013 | 0.468 |
Vitiligo-Female | 0.007 | −0.018; 0.032 | 0.013 | 0.593 |
Vitiligo-M/F Ratio | 0.030 | −0.073; 0.134 | 0.053 | 0.566 |
Controls -Male | 0.038 | 0.001; 0.075 | 0.019 | 0.044 |
Controls -Female | 0.031 | −0.007; 0.068 | 0.019 | 0.107 |
Controls -M/F Ratio | 0.030 | −0.073; 0.134 | 0.053 | 0.566 |
Vitiligo-Age | 0.042 | −0.056; 0.140 | 0.050 | 0.405 |
Controls-Age | 0.012 | −0.105; 0.130 | 0.060 | 0.837 |
Disease duration | −0.021 | −0.261; 0.219 | 0.122 | 0.863 |
Year | −0.086 | −0.313; 0.140 | 0.116 | 0.455 |
Country | 0.194 | 0.041; 0.347 | 0.078 | 0.013 |
Method | −0.450 | −1.206; 0.306 | 0.386 | 0.243 |
NOS | −0.166 | −0.756; 0.425 | 0.301 | 0.583 |